about
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are meta...
Read More
8.48
-0.27
(-3.09%)
287.1K
XNAS Volume
XNAS 31 Jul, 2025 2:00 PM (EDT)
Board Meeting
The next board meeting for Regenxbio Inc is on 01 Aug 2025 for the purpose of Regenxbio Inc Second Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Regenxbio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..